CompoAtlas

First Colloidal Gel Antibactérien

Natural health product licensed in Canada

Licence holder
First Colloidal Inc.
NPN or DIN-HM
80104746
Status
Active licence
Licence date
2 October 2020
Revision date
19 April 2022
Form
Gel
Route of administration
Topique
Application type
Générale (non traditionelle)

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Argent

Source : Argent colloïdal

0.002 %

Non-medicinal ingredients

Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Acide citrique, Extrait d'Aloe barbadensis, Eau purifiée, Cocoate de PEG-7 glycéryle, Glycérine, Tocophérols, Triéthanolamine

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedNot specifiedminimum: 1 day ; maximum: 2 days

Uses authorised in Canada

Utilisé comme antibactérien pour aider à favoriser la guérison des plaies et brûlures mineures.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80104746

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line